Evexcell™ Processed RMT
Regenerative Medicine (unspecified)
Pre-clinicalActive
Key Facts
About Frontier Biologics
Founded in 2020 and headquartered in Waco, Texas, Frontier Biologics is a private, pre-revenue biotech focused on regenerative medicine. The company's core asset is its Evexcell™ processing platform, which gently processes donated birth tissues to produce acellular biologic therapies. With a state-of-the-art cGMP facility and an initial IND submission targeted for Q1 2023, Frontier aims to establish itself in the growing regenerative medicine market by prioritizing product safety, efficacy, and regulatory compliance.
View full company profileTherapeutic Areas
Other Regenerative Medicine (unspecified) Drugs
| Drug | Company | Phase |
|---|---|---|
| Stem Cell Clinical Program | Aelan Cell Technologies | Pre-clinical |